SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NexStar Pharm(NXTR)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
328 5 0 NXTR
Emcee:  Miljenko Zuanic Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
28 Very interesting patent for NXTR. I wonder if the production of such small lipWWS-1/23/1997
27 New Patent, Liposomal targeting of ischemic tissue (Assignee -- NeXstar PharMiljenko Zuanic-1/23/1997
26 Colorado Bio Investment Conference 1997 To Be Held Wednesday, February 26 throuMiljenko Zuanic-1/23/1997
25 Court decision-sales prosperity? Before I elaborate this question, I am submitMiljenko Zuanic-1/21/1997
24 Barron, just two weeks ago I predicted here that this thread was soon going to WWS-1/20/1997
23 Here's an idea of the market for Ambisome or antifungals Friday January 17Barron Von Hymen-1/20/1997
22 but is this lawsuit really key to the stock's performance in the long run?Barron Von Hymen-1/19/1997
21 On the science bench, innovation is an easy word to apply to anyone's idea.Barron Von Hymen-1/19/1997
20 Barron, thank you for your insights about the next substances that NXTR is adopWWS-1/19/1997
19 Well they are certainly interested in the right drugs for anti-cancer therapy. Barron Von Hymen-1/19/1997
18 Bill, I agree with you. SELEX-PARS combination , IMO, will account for >50% Miljenko Zuanic-1/19/1997
17 Bill, your starting point for analyzing NXTR could be their own web site, whereWWS-1/18/1997
16 I have only started to look at the co. in the last several days. Accordingly myBill Tomko-1/18/1997
15 Miljenko, An excellent summation of NXTR's products and prospects! I wouldWWS-1/18/1997
14 Hi Barron, Glad to have you here. In short, the answers are: 1. NXTR currentMiljenko Zuanic-1/18/1997
13 Stock trend interests me, further investigation shows to me an interesting stocBarron Von Hymen-1/17/1997
12 Miljenko, while I do monitor news sources closely on the stocks I own or followWWS-1/9/1997
11 Bill, Thanks for the link. By attempt to catch you with good news, obviously IMiljenko Zuanic-1/9/1997
10 Miljenko, I could find nothing in the DJIS news on the NXTR/Boehringer collaborWWS-1/9/1997
9 Miljenko, The fact that you're an organic chemist helps make clear to me thWWS-1/9/1997
8 Bill, Nice article about NeXstar's new technology-PASS(Business wire). As Miljenko Zuanic-1/9/1997
7 Bill, Thanks for a friendly advice on CNSI. I am avare of Cerestat side effectMiljenko Zuanic-1/7/1997
6 Miljenko, I was looking over recent postings on a company, CNSI, in which I useWWS-1/5/1997
5 Miljenko, I have faith in the management of NXTR. Their approach to get a drugWWS-1/5/1997
4 Bill, Glad that you are enthusiastic on NXTR prosperity, as I am. I bought NXTMiljenko Zuanic-1/5/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):